A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response?

Biochemical Pharmacology

Volumn 59, Issue 5, 2000, Pages 455-465

  Johnson, Pauline ^a   Maiti, Arpita ^a   Brown, Kelly L ^a   Li, Ruihong ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CD44; Cell adhesion; Inflammation; Leukocyte endothelial cell interactions; Sulfation; TNF

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; HYALURONIC ACID; SELECTIN;

ANGIOGENESIS; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL TYPE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; EXTRAVASATION; HUMAN; INFLAMMATION; LEUKOCYTE; LIGAND BINDING; LYMPHOPOIESIS; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; SULFATION; WOUND HEALING;

EID: 0033977292     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00266-X     Document Type: Article

References (113)

1. Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U., Bell J.I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 89:1992;12160-12164.
2. Yang B., Yang B.L., Savani R.C., Turley E.A. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13:1994;286-296.
3. Stamenkovic I., Amiot M., Pesando J.M., Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell. 56:1989;1057-1062.
4. Lesley J., Hyman R. CD44 structure and function. Front Biosci. 3:1998;616-630.
5. Goldstein L.A., Zhou D.F.H., Picker L.J., Minty C.N., Bargatze R.F., Ding J.F., Butcher E.C. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell. 56:1989;1063-1072.
6. Kohda D., Morton C.J., Parkar A.A., Hatanaka H., Inagaki F.M., Campbell I.D., Day A.J. Solution structure of the link module A hyaluronan-binding domain involved in extracellular matrix stability and cell migration . Cell. 86:1996;767-775.
7. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration. Cell. 76:1994;301-314.
8. Tedder T.F., Steeber D.A., Chen A., Engel P. The selectins Vascular adhesion molecules . FASEB J. 9:1995;866-873.
9. Lasky L.A. Selectin-carbohydrate interactions and the initiation of the inflammatory response. Annu Rev Biochem. 64:1995;113-139.
10. Peach R.J., Hollenbaugh D., Stamenkovic I., Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol. 122:1993;257-264.
11. Bajorath J., Greenfield B., Munro S.B., Day A.J., Aruffo A. Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. J Biol Chem. 273:1998;338-343.
12. Kincade P.W., Zheng Z., Katoh S., Hanson L. The importance of cellular environment to function of the CD44 matrix receptor. Curr Opin Cell Biol. 9:1997;635-642.
13. Lesley J., Hyman R., English N., Catterall J.B., Turner G.A. CD44 in inflammation and metastasis. Glycoconj J. 14:1997;611-622.
14. Liu D.C., Sy M.S. Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. J Immunol. 159:1997;2702-2711.
15. Li R., Walker J.R., Johnson P. Chimeric CD4/CD44 molecules associate with CD44 via the transmembrane region and reduce hyaluronan binding in T cell lines. Eur J Immunol. 28:1998;1745-1754.
16. Lesley J., He Q., Miyake K., Hamann A., Hyman R., Kincade P.W. Requirements for hyaluronic acid binding by CD44 A role for the cytoplasmic domain and activation by antibody . J Exp Med. 175:1992;257-266.
17. Liao H.-X., Levesque M.C., Patton K., Bergamo B., Jones D., Moody M.A., Telen M.J., Haynes B.F. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol. 151:1993;6490-6499.
18. Lokeshwar V.B., Fregien N., Bourguignon L.Y.W. Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion. J Cell Biol. 126:1994;1099-1109.
19. Perschl A., Lesley J., English N., Trowbridge I., Hyman R. Role of CD44 cytoplasmic domain in hyaluronan binding. Eur J Immunol. 25:1995;495-501.
20. Liu D., Zhang D., Mori H., Sy M.-S. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain. Cell Immunol. 174:1996;73-83.
21. Thomas L., Byers H.R., Vink J., Stamenkovic I. CD44H regulates tumour cell migration on hyaluronate-coated substrates. J Cell Biol. 118:1992;971-977.
22. Neame S.J., Isacke C.M. The cytoplasmic tail of CD44 is required for basolateral localization in epithelial MDCK cells but does not mediate association with the detergent-insoluble cytoskeleton of fibroblasts. J Cell Biol. 121:1993;1299-1310.
23. Sheikh H., Isacke C.M. A di-hydrophobic Leu-Val motif regulates the basolateral localization of CD44 in polarized Madin-Darby canine kidney epithelial cells. J Biol Chem. 271:1996;12185-12190.
24. Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J.J.L., Ohashi P.S., Paige C.J., Gutierrez-Ramos J.C., Mak T.W. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood. 90:1997;2217-2233.
25. Miyake K., Underhill C.B., Lesley J., Kincade P.W. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med. 172:1990;69-75.
26. Lesley J., Schulte R., Hyman R. Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res. 187:1990;224-233.
27. Aruffo A., Stamenkovic I., Melnick M., Underhill C.B., Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61:1990;1303-1313.
28. Herrlich P., Zoller M., Pals S.T., Ponta H. CD44 splice variants Metastases meet lymphocytes . Immunol Today. 14:1993;395-399.
29. Ponta H., Wainwright D., Herrlich P. The CD44 protein family. Int J Biochem Cell Biol. 30:1998;299-305.
30. Peck D., Isacke C.M. CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Curr Biol. 6:1996;884-890.
31. Henke C.A., Roongta U., Mickelson D.J., Knutson J.R., McCarthy J.B. CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J Clin Invest. 97:1996;2541-2552.
32. Lesley J., Hyman R., Schulte R. Evidence that the Pgp-1 glycoprotein is expressed on thymus-homing progenitor cells of the thymus. Cell Immunol. 91:1985;397-403.
33. Wu L., Kincade P.W., Shortman K. The CD44 expressed on the earliest intrathymic precursor population functions as a thymus homing molecule but does not bind to hyaluronate. Immunol Lett. 38:1993;69-75.
34. Toyama-Sorimachi N., Miyasaka M. A novel ligand for CD44 is sulfated proteoglycan. Int Immunol. 6:1994;655-660.
35. Toyama-Sorimachi N., Sorimachi H., Tobita Y., Kitamura F., Yagita H., Suzuki K., Miyasaka M. A novel ligand for CD44 is serglycin, a hematopoietic cell lineage-specific proteoglycan. J Biol Chem. 270:1995;7437-7444.
36. Naujokas M.F., Morin M., Anderson M.S., Peterson M., Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell. 74:1993;257-268.
37. Sleeman J.P., Kondo K., Moll J., Ponta H., Herrlich P. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J Biol Chem. 272:1997;31837-31844.
38. Moll J., Khaldoyanidi S., Sleeman J.P., Achtnich M., Preuss I., Ponta H., Herrlich P. Two different functions for CD44 proteins in human myelopoiesis. J Clin Invest. 102:1998;1024-1034.
39. Chiu R.K., Droll A., Dougherty S.T., Carpenito C., Cooper D.L., Dougherty G.J. Alternatively spliced CD44 isoforms containing exon v10 promote cellular adhesion through the recognition of chondroitin sulfate-modified CD44. Exp Cell Res. 248:1999;314-321.
40. Weber G.F., Ashkar S., Glimcher M.J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science. 271:1996;509-512.
41. Katagiri Y.U., Sleeman J., Fujii H., Herrlich P., Hotta H., Tanaka K., Chikuma S., Yagita H., Okumura K., Murakami M., Saiki I., Chambers A.F., Uede T. CD44 variants but not CD44s cooperate with β1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59:1999;219-226.
42. Jalkanen S., Jalkanen M. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol. 116:1992;817-825.
43. Ehnis T., Dieterich W., Bauer M., von Lampe B., Schuppan D. A chondroitin/dermatan sulfate form of CD44 is a receptor for collagen XIV (undulin). Exp Cell Res. 229:1996;388-397.
44. Faassen A.E., Schrager J.A., Klein D.J., Oegema T.R., Couchman J.R., McCarthy J.B. A cell surface chondroitin sulfate proteoglycan, immunologically related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol. 116:1992;521-531.
45. Knutson J.R., Iida J., Fields G.B., McCarthy J.B. CD44/chondroitin sulfate proteoglycan and α-2-β-1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes. Mol Biol Cell. 7:1996;383-396.
46. Tanaka Y., Adams D.H., Hubscher S., Hirano H., Siebenlist U., Shaw S. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β Nature. 361:1993;79-82.
47. Yu Q., Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13:1999;35-48.
48. Bennett K.L., Jackson D.G., Simon J.C., Tanczos E., Peach R., Modrell B., Stamenkovic I., Plowman G., Aruffo A. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol. 128:1995;687-698.
49. Toole B.P. Hyaluronan and its binding proteins, the hyaladherins. Curr Opin Cell Biol. 2:1990;839-844.
50. Knudson C.B., Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 7:1993;1233-1241.
51. Campbell R.D., Love S.H., Whiteheart S.W., Young B., Myrvik Q.N. Increased hyaluronic acid is associated with dermal delayed-type hypersensitivity. Inflammation. 6:1982;235-244.
52. Entwistle J., Hall C.L., Turley E.A. HA receptors Regulators of signalling to the cytoskeleton . J Cell Biochem. 61:1996;569-577.
53. Murakami S., Saho T., Asari A., Hino E., Kasai D., Shimabukuro Y., Okada H. CD44-hyaluronate interaction participates in the adherence of T-lymphocytes to gingival fibroblasts. J Dental Res. 75:1996;1545-1552.
54. Legras S., Levesque J.P., Charrad R., Morimoto K., Le Bousse C., Clay D., Jasmin C., Smadja-Joffe F. CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines. Blood. 89:1997;1905-1914.
55. Hyman R., Lesley J., Schulte R. Somatic cell mutants distinguish CD44 expression and hyaluronic acid binding. Immunogenetics. 33:1991;392-395.
56. Lesley J., Hyman R., Kincade P.W. CD44 and its interaction with the extracellular matrix. Adv Immunol. 54:1993;271-335.
57. Sleeman J., Rudy W., Hofmann M., Moll J., Herrlich P., Ponta H. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol. 135:1996;1139-1150.
58. Skelton T.P., Zeng C.X., Nocks A., Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol. 140:1998;431-446.
59. Lesley J., Kincade P.W., Hyman R. Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur J Immunol. 23:1993;1902-1909.
60. Galandrini R., Galluzzo E., Albi N., Grossi C.E., Velardi A. Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J Immunol. 153:1994;21-31.
61. DeGrendele H.C., Estess P., Picker L.J., Siegelman M.H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow A novel lymphocyte-endothelial cell primary adhesion pathway . J Exp Med. 183:1996;1119-1130.
62. DeGrendele H.C., Kosfiszer M., Estess P., Siegelman M.H. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J Immunol. 159:1997;2549-2553.
63. Murakami S., Miyake K., Abe R., Kincade P.W., Hodes R.J. Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. J Immunol. 146:1991;1422-1427.
64. Lesley J., Howes N., Perschl A., Hyman R. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J Exp Med. 180:1994;383-387.
65. DeGrendele H.C., Estess P., Siegelman M.H. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 278:1997;672-675.
66. Murakami S., Miyake K., June C.H., Kincade P.W., Hodes R.J. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J Immunol. 145:1990;3618-3627.
67. Levesque M.C., Haynes B.F. In vitro culture of human peripheral blood monocytes induces hyaluronan binding and up-regulates monocyte variant CD44 isoform expression. J Immunol. 156:1996;1557-1565.
68. Levesque M.C., Haynes B.F. Cytokine induction of the ability of human monocyte CD44 to bind hyaluronan is mediated primarily by TNF-α and is inhibited by IL-4 and IL-13. J Immunol. 159:1997;6184-6194.
69. Mackay F., Loetscher H., Stueber D., Gehr G., Lesslauer W. Tumor necrosis factor α (TNF-α)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med. 177:1993;1277-1286.
70. Mohamadzadeh M., DeGrendele H., Arizpe H., Estess P., Siegelman M. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest. 101:1998;97-108.
71. Eggli P.S., Graber W. Association of hyaluronan with rat vascular endothelial and smooth muscle cells. J Histochem Cytochem. 43:1995;689-697.
72. Koopman G., Taher T.E., Mazzucchelli I., Keehnen R.M., van der Voort R., Manten-Horst E., Ricevuti G., Pals S.T. and Das PK, CD44 isoforms, including the CD44 v3 variant, are expressed on endothelium, suggesting a role for CD44 in the immobilization of growth factors and the regulation of the local immune response. Biochem Biophys Res Commun. 245:1998;172-176.
73. Arch R., Wirth K., Hofmann M., Ponta H., Matzku S., Herrlich P., Zoller M. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science. 257:1992;682-685.
74. Koopman G., Heider K.-H., Horst E., Adolf G.R., van den Berg F., Ponta H., Herrlich P., Pals S.T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med. 177:1993;897-904.
75. Hathcock K.S., Hirano H., Murakami S., Hodes R.J. CD44 expression on activated B cells Differential capacity for CD44-dependent binding to hyaluronic acid . J Immunol. 151:1993;6712-6722.
76. Camp R.L., Kraus T.A., Pure E. Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. J Cell Biol. 115:1991;1283-1292.
77. Maiti A., Maki G., Johnson P. TNF-α induction of CD44-mediated leukocyte adhesion by sulfation. Science. 282:1998;941-943.
78. Girard J.P., Springer T.A. High endothelial venules (HEVs) Specialized endothelium for lymphocyte migration . Immunol Today. 16:1995;449-457.
79. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis. Science. 272:1996;60-66.
80. Watson S.R., Bradley L.M. The recirculation of naive and memory lymphocytes. Cell Adhes Commun. 6:1998;105-110.
81. Jalkanen S., Bargatze R.F., de los Toyos J., Butcher E.C. Lymphocyte recognition of high endothelium Antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells . J Cell Biol. 105:1987;983-990.
82. Culty M., Miyake K., Kincade P.W., Silorski E., Butcher E.C., Underhill C. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol. 111:1990;2765-2774.
83. Stamenkovic I., Aruffo A., Amiot M., Seed B. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 10:1991;343-348.
84. Camp R.L., Scheynius A., Johansson C., Pure E. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med. 178:1993;497-507.
85. Clark R.A., Alon R., Springer T.A. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol. 134:1996;1075-1087.
86. Jalkanen S., Jalkanen M., Bargatze R., Tammi M., Butcher E.C. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol. 141:1988;1615-1623.
87. Sleeman J.P., Rahmsdorf U., Steffen A., Ponta H., Herrlich P. CD44 variant exon v5 encodes a tyrosine that is sulphated. Eur J Biochem. 255:1998;74-80.
88. Rosen S.D., Bertozzi C.R. The selectins and their ligands. Curr Opin Cell Biol. 6:1994;663-673.
89. Varki A. Selectin ligands. Proc Natl Acad Sci USA. 91:1994;7390-7397.
90. Rosen S.D., Hwang S.T., Giblin P.A., Singer M.S. High-endothelial-venule ligands for L-selectin Identification and functions . Biochem Soc Trans. 25:1997;428-433.
91. Varki A. Selectin ligands Will the real ones please stand up? J Clin Invest. 100:(Suppl 11):1997;S31-S35.
92. McEver R.P. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J. 14:1997;585-591.
93. Andrews P., Milsom D.W., Ford W.L. Migration of lymphocytes across specialized vascular endothelium. V. Production of a sulphated macromolecule by high endothelial cells in lymph nodes. J Cell Sci. 57:1982;277-292.
94. Rosen S.D., Bertozzi C.R. Leukocyte adhesion Two selectins converge on sulphate . Curr Biol. 6:1996;261-264.
95. Imai Y., Lasky L.A., Rosen S.D. Sulphation requirement for GlyCAM-1, an endothelial ligand for L-selectin. Nature. 361:1993;555-557.
96. Hemmerich S., Butcher E.C., Rosen S.D. Sulfation-dependent recognition of high endothelial venules (HEV)-ligands by L-selectin and MECA 79, an adhesion-blocking monoclonal antibody. J Exp Med. 180:1994;2219-2226.
97. Sako D., Chang X.J., Barone K.M., Vachino G., White H.M., Shaw G., Veldman G.M., Bean K.M., Ahern T.J., Furie B., Cumming D.A., Larsen G.R. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 75:1993;1179-1186.
98. Sako D., Comess K.M., Barone K.M., Camphausen R.T., Cumming D.A., Shaw G.D. A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding. Cell. 83:1995;323-331.
99. Pouyani T., Seed B. PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell. 83:1995;333-343.
100. Wilkins P.P., Moore K.L., McEver R.P., Cummings R.D. Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin. J Biol Chem. 270:1995;22677-22680.
101. Norgard-Sumnicht K.E., Varki N.M., Varki A. Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells. Science. 261:1993;480-483.
102. Crocker P.R., Feizi T. Carbohydrate recognition systems Functional triads in cell-cell interactions . Curr Opin Struct Biol. 6:1996;679-691.
103. Li Y.F., Kawashima H., Watanabe N., Miyasaka M. Identification and characterization of ligands for L-selectin in the kidney. II. Expression of chondroitin sulfate and heparan sulfate proteoglycans reactive with L-selectin. FEBS Lett. 444:1999;201-205.
104. Steegmaier M., Levinovitz A., Isenmann S., Borges E., Lenter M., Kocher H.P., Kleuser B., Vestweber D. The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature. 373:1995;615-620.
105. Fuhlbrigge R.C., Kieffer J.D., Armerding D., Kupper T.S. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature. 389:1997;978-981.
106. Li F., Wilkins P.P., Crawley S., Weinstein J., Cummings R.D., McEver R.P. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J Biol Chem. 271:1996;3255-3264.
107. Brockhausen I., Kuhn W. Role and metabolism of glycoconjugate sulfation. Trends Glycosci Glycotechnol. 9:1997;379-398.
108. Giordanengo V., Limouse M., Peyron J.F., Lefebvre J.C. Lymphocytic CD43 and CD45 bear sulfate residues potentially implicated in cell to cell interactions. Eur J Immunol. 25:1995;274-278.
109. Farzan M., Mirzabekov T., Kolchinsky P., Wyatt R., Cayabyab M., Gerard N.P., Gerard C., Sodroski J., Hyeryun C. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell. 96:1999;667-676.
110. WuDunn D., Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol. 63:1989;52-58.
111. Bowman K.G., Hemmerich S., Bhakta S., Singer M.S., Bistrup A., Rosen S.D., Bertozzi C.R. Identification of an N-acetylglucosamine-6-O-sulfotransferase activity specific to lymphoid tissue An enzyme with a possible role in lymphocyte homing . Chem Biol. 5:1998;447-460.
112. Uchimura K., Muramatsu H., Kadomatsu K., Fan Q.W., Kurosawa N., Mitsuoka C., Kannagi R., Habuchi O., Muramatsu T. Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase. J Biol Chem. 273:1998;22577-22583.
113. Li X., Tedder T.F. CHST1 and CHST2 sulfotransferases expressed by human vascular endothelial cells cDNA cloning, expression, and chromosomal localization . Genomics. 55:1999;345-347.